Search

everythinglearnresearchcommunity

for

Search:↓

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

The model better predicts how water-loving and fat-loving substances move through the skin by including tiny pores and hair follicle paths.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Dihydrotestosterone increases arterial stiffness in female mice without changing blood pressure or aortic wall thickness.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Children are at risk of health issues from exposure to platinum group elements from car exhausts.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Patients with mycosis fungoides have a higher risk of heart disease.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Balding men have higher heart disease risk.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Using electronic health records can help identify drug side effects but has some limitations.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.